PDB14 COST-EFFECTIVENESS OF MONO- AND COMBINATION THERAPY WITH PIOGLITAZONE COMPARED TO GLICLAZIDE IN PATIENTS WITH TYPE-2-DIABETES MELLITUS FROM A GERMAN STATUTORY HEALTH CARE PERSPECTIVE
Abstract
Authors
W Schramm K Neeser O Mast G Lbben A Ltke